BIOFRONTERA INC.

(BFRI)
  Rapport
Temps Différé Nasdaq  -  22:00 09/08/2022
1.410 USD   -2.76%
01/08Les conseils d'administration et de surveillance de Biofrontera recommandent aux actionnaires de rejeter l'offre d'acquisition de Deutsche Balaton
MT
01/08Biofrontera reçoit un brevet australien pour la thérapie photodynamique destinée à traiter les maladies de la peau
MT
12/07Biofrontera Inc. fournit des prévisions de revenus pour le deuxième trimestre et les six mois se terminant le 30 juin 2022.
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur BIOFRONTERA INC.
04/08Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
04/08Biofrontera Inc. to Report Second Quarter Financial Results on August 12, 2022
01/08Biofrontera's Management, Supervisory Boards Recommend Shareholders Reject Deutsche Bal..
01/08Biofrontera Receives Australian Patent for Photodynamic Therapy to Treat Skin Diseases
01/08Biofrontera Inc. Announces Patent in Australia for Novel Illumination Protocols Granted..
28/07BIOFRONTERA : Announces Exercise of Existing Warrants and Issuance of Warrants in Private ..
28/07BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity..
27/07Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr..
27/07Biofrontera Inc. Announces Exercise of Existing Warrants and Issuance of Warrants in Pr..
12/07BIOFRONTERA : Announces Preliminary Product Revenues for the Second Quarter of 2022 - Form..
12/07Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
12/07Biofrontera Inc. Announces Preliminary Product Revenues for the Second Quarter of 2022
12/07Biofrontera Inc. Provides Revenue Guidance for the Second Quarter and Six Months Ended ..
24/06BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell 3000E Value Index
24/06BIOFRONTERA INC.(NASDAQCM : BFRI) dropped from Russell Microcap Value Index
09/06Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing..
09/06Biofrontera, Inc. Recognized for Rapid Sales Growth, Innovative Therapies and Marketing..
31/05Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf..
31/05Biofrontera Inc. to Participate in The Benchmark Healthcare House Call Virtual 1x1 Conf..
24/05BIOFRONTERA INC. : Change in Directors or Principal Officers, Other Events, Financial Stat..
24/05BIOFRONTERA INC. Change in Directors or Principal Officers (form 8-K/A)
24/05Biofrontera Inc. Appoints Kevin D. Weber to the Nominating and Corporate Governance, Au..
24/05New Data and Forecasts for the U.S. Skin Cancer Market Strongly Support the Commercial ..
23/05Biofrontera Inc. announced that it has received $9.40068 million in funding
20/05BIOFRONTERA : Announces Pricing of $9.4 Million Private Placement - Form 8-K
20/05BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity..
19/05Biofrontera Inc. Announces Closing of $9.4 Million Private Placement
17/05NACHBÖRSE/XDAX +0,4% auf 14.237 Pkt - Tui-Aktie unter Druck
16/05Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
16/05Biofrontera Inc. Announces Pricing of $9.4 Million Private Placement
16/05Biofrontera Inc. announced that it expects to receive $9.40225 million in funding
13/05Earnings Flash (BFRI) BIOFRONTERA Posts Q1 Revenue $9.8M, vs. Street Est of $9.83M
13/05Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U..
13/05Biofrontera Inc. Reports First Quarter 2022 Financial Results and Provides a Business U..
13/05Biofrontera Inc. Re-Affirms Earnings Guidance for 2022
13/05BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul..
13/05Biofrontera Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
06/05Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
06/05Biofrontera Inc. to Report First Quarter Financial Results on May 13, 2022
05/05Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f..
05/05Biofrontera Inc. to Showcase Actinic Keratosis Treatments at the Music City Symposium f..
27/04Certain Common Stock of Biofrontera Inc. are subject to a Lock-Up Agreement Ending on 2..
21/04Biofrontera Launches New Patient-Focused Websites for Ameluz® and Xepi®
14/04Biofrontera Shares Retreat 7% After Wednesday's Big Move Higher
13/04Top Midday Gainers
13/04Biofrontera Shares Jump 31% After FDA Approves Contract Laboratory for Ameluz
13/04Biofrontera Says FDA Has Approved German Facility as Contract Laboratory for Testing of..
13/04Biofrontera Shares Halted After FDA Approves German Lab for Testing Ameluz
13/04Biofrontera Inc. Announces FDA Approval of Biofrontera Pharma GmbH as a Contract Labora..
11/04Top Premarket Decliners
11/04BIOFRONTERA INC. Management's Discussion and Analysis of Financial Condition and Resul..
08/04SECTOR UPDATE : Health Care Stocks Enjoy Late Uptick
08/04SECTOR UPDATE : Health Care Stocks Firming in Mostly Higher Market
08/04SECTOR UPDATE : Health Care
08/04European ADRs Move Higher in Friday Trading
08/04Biofrontera Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended De..
08/04Top Premarket Gainers
08/04Earnings Flash (BFRI) BIOFRONTERA Reports Q4 Revenue $9.2M, vs. Street Est of $9.2M
08/04Biofrontera Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provid..
06/04BIOFRONTERA : Announces Preliminary Product Revenues for the First Quarter of 2022 - Form ..
06/04Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
06/04Biofrontera Inc. Announces Preliminary Product Revenues for the First Quarter of 2022
05/04BIOFRONTERA INC. : Entry into a Material Definitive Agreement, Change in Directors or Prin..
04/04European ADRs Nudge Higher in Monday Trading
01/04Biofrontera Inc. to Report Fourth Quarter and Full Year 2021 Financial Results on April..
30/03European ADRs Move Higher in Wednesday Trading
17/03Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American ..
17/03European ADRs Nudge Higher in Thursday Trading
14/03Biofrontera Inc. Announces FDA Orange Book Listing of U.S. Patent for BF-RhodoLED® XL, ..
09/03Biofrontera Inc. to Present at the 34th Annual Roth Conference
08/03BIOFRONTERA INC. : Change in Directors or Principal Officers, Financial Statements and Exh..
07/03Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors
07/03Biofrontera Inc. Appoints Kevin D. Weber to its Board of Directors
01/02Top Midday Gainers
01/02Biofrontera Completes 70% of Enrollment in Phase 3 of Skin Cancer Study; Shares Rise
1  2Suiv.
Prochain événement sur BIOFRONTERA INC.